This group likely includes patients with a familial hypercholesterolemia phenotype, in whom AVS risk is increased such that the contribution of Lp(a) is relatively small, or perhaps that patients die of atherosclerotic disease before any AVS diagnosis can be made. The gene discussed is LPA; the disease is familial hypercholesterolemia.